| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |